Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), the most common form of liver cancer, has become a major global health problem and is responsible for a steadily increasing number of cancer-related deaths. Although the risk factors for HCC development are well known and great advances have been made through HBV vacc...

Full description

Saved in:
Bibliographic Details
Other Authors: Tirnitz-Parker, Janina EE (Editor)
Format: Electronic Book Chapter
Language:English
Published: Australia Exon Publications 2019
Subjects:
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_81832
005 20220521
003 oapen
006 m o d
007 cr|mn|---annan
008 20220521s2019 xx |||||o ||| 0|eng d
020 |a hepatocellularcarcinoma.2019 
020 |a 9780994438188 
040 |a oapen  |c oapen 
024 7 |a 10.15586/hepatocellularcarcinoma.2019  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a MJCL  |2 bicssc 
100 1 |a Tirnitz-Parker, Janina EE  |4 edt 
700 1 |a Tirnitz-Parker, Janina EE  |4 oth 
245 1 0 |a Hepatocellular Carcinoma 
260 |a Australia  |b Exon Publications  |c 2019 
300 |a 1 electronic resource (165 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Hepatocellular carcinoma (HCC), the most common form of liver cancer, has become a major global health problem and is responsible for a steadily increasing number of cancer-related deaths. Although the risk factors for HCC development are well known and great advances have been made through HBV vaccinations, direct-acting antivirals for HCV treatment, and aflatoxin eradication programs, the overall incidence and mortality rates of HCC are still rising. To tackle the burden of HCC, it is essential to understand the principle molecular and cellular processes as well as fundamental clinical challenges. This book provides an overview on several important disease aspects. Chapter 1 reviews recent studies assessing the potential cellular origins of HCC. Chapter 2 describes the newly discovered regulatory roles of the tumor microenvironment on tumor growth and progression. Chapters 3 and 4 outline the most commonly used in vitro systems and animal models of chronic liver disease and HCC in detail. Chapter 5 provides an overview of metabolic reprogramming and dysregulation of lipid metabolism as a newly recognized hallmark of HCC. Chapter 6 details the currently accepted standards and challenges for the surgical management of HCC, while Chapter 7 provides an overview of the recent developments in the field of tyrosine kinase inhibitors. Chapter 8 discusses multidrug resistance to chemotherapy and potential approaches to overcome this clinical obstacle. The book, written by experts from several countries, addresses each topic in sophisticated detail. It will be a valuable resource for clinicians and investigators who are interested in HCC. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by-nc-nd/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by-nc-nd/4.0/ 
546 |a English 
650 7 |a MJCL  |2 bicssc 
653 |a Hepatocellular Carcinoma 
856 4 0 |a www.oapen.org  |u https://exonpublications.com/index.php/exon/issue/view/10  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/81832  |7 0  |z DOAB: description of the publication